MedPath

Exametazime

Generic Name
Exametazime
Drug Type
Small Molecule
Chemical Formula
C13H28N4O2
CAS Number
105613-48-7
Unique Ingredient Identifier
G29272NCKL

Overview

Exametazime is a diagnostic radiopharmaceutical agent commonly used for the preparation of Tc99m Exametazime injection. It acts as a chelating agent for the radioisotope technetium-99m to form a cationic complex. It is used in the detection of altered regional cerebral perfusion and for the radiolabeling of autologous leukocytes.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor

No clinical trials found

No clinical trials found for this drug

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
AnazaoHealth Corporation
51808-214
INTRAVENOUS
1 mg in 1 1
11/28/2012

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
CERETEC kit for preparation of technetium (99mTc) exametazime powder for injection vial
10018
Medicine
A
9/23/1991

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
No Health Canada approvals found for this drug.

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
EXAMETAZIMA RADIOPHARMACY 500 MICROGRAMOS EQUIPO DE REACTIVOS PARA PREPARACION RADIOFARMACEUTICA EFG
Radiopharmacy Laboratorium Kft.
77468
EQUIPO DE REACTIVOS PARA PREPARACIÓN RADIOFARMACÉUTICA
Uso Hospitalario
Commercialized
CERETEC 500 MICROGRAMOS EQUIPO DE REACTIVOS PARA PREPARACIÓN RADIOFARMACÉUTICA
Ge Healthcare Bio-Sciences, S.A.U.
61024
EQUIPO DE REACTIVOS PARA PREPARACIÓN RADIOFARMACÉUTICA
Uso Hospitalario
Commercialized
CERETEC ESTABILIZADO 500 MICROGRAMOS EQUIPO DE REACTIVOS PARA PREPARACIÓN RADIOFARMACÉUTICA
Ge Healthcare Bio-Sciences, S.A.U.
62666
EQUIPO DE REACTIVOS PARA PREPARACIÓN RADIOFARMACÉUTICA
Uso Hospitalario
Commercialized

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.